The supply of anti-viral medicine for treatment of Influenza A(H1N1) is sufficient to meet the needs of patients in government hospitals and clinics, as well as those in private hospitals, vice-president of the Malaysian Organisation of Pharmaceutical Industries (MOPI) Leonard Ariff Abd Shatar said today.
He said there would be no shortage of the anti-viral medicine, including Tamiflu (oseltamivir phosphate), which was used in the treatment of influenza.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment